Delivery Order SPE2DB25D3012-SPE2DB25FWXNU
- Not listed
- The Defense Logistics Agency awarded a Delivery Order valued at $5,854.08 to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Ketamine 200 mg/20 ml vials. The contract is a firm fixed-price delivery order with an ultimate completion date of September 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This non-set-aside award was competitively awarded and represents a child order under AmerisourceBergen Drug Corp's broader contracting...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Ketamine 200 mg/20 mL vials. This firm fixed-price delivery order, valued at $1,074.15, represents a competitive award with no set-aside designation and is scheduled for completion by September 19, 2025. The product will be delivered to the vendor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $4,651.52 to AmerisourceBergen Drug Corp for the supply of Ketamine 200 mg/20 mL vials. This firm fixed-price contract, awarded on August 22, 2025, represents a competitive procurement with no set-aside designation and carries an ultimate completion date of August 25, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance for this pharmaceutical supply delivery. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,968.20 to AmerisourceBergen Drug Corp for the supply of Ketamine 200 mg/20 ml vials. This non-competitive, firm fixed-price delivery order was awarded on August 20, 2025, with an ultimate completion date of August 21, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,005.60 for 500 mg/5 mL ketamine vials on August 14, 2025, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price delivery order represents a procurement of pharmaceutical product for federal medical supply needs. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order valued at $4,847.38 to AmerisourceBergen Drug Corp for the supply of Ketamine 200 mg/20 mL vials on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed price, competitively awarded delivery order will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a non-set-aside procurement, reflecting AmerisourceBergen's demonstrated capability to compete in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Ketamine 500 mg/5 mL vials with a ceiling value of $1,187.48. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively rendered. The contract is expected to reach ultimate completion by September 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Ketamine 500mg/5mL in quantities of 10, with a ceiling value of $1,076.58 and an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award represents a continuation of...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,566,024,939 units of Ketamine 500 mg/5 ml vial, 5 ml, at a ceiling value of $1,156.20. The contract is a firm fixed-price delivery order with an ultimate completion date of October 7, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency awarded a firm fixed price delivery order contract valued at $2,530.74 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 500 mg/10 mL vials of the injectable anesthetic medication Ketamine. The contract has a completion date of February 12, 2024. AmerisourceBergen Drug Corp, a for-profit organization, serves as the prime contractor and sole awardee on this delivery order. The contract is not associated with any...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FWXNUDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,978.80 to AmerisourceBergen Drug Corp on May 27, 2025, for the supply of Ketamine 200 mg/20 mL vials. This non-set-aside, firm fixed-price contract is scheduled for completion by May 28, 2025, with performance at the vendor's facility in Conshohocken, Pennsylvania. The delivery order represents a competitive procurement action under the company's existing contract vehicle with DLA. This award falls under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of pharmaceuticals and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, holds a critical role in federal medical procurement and supplies medications, vaccines, and specialized medical commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 5/27/25 |